Kári Stefánsson
Chief Executive Officer bij deCODE Genetics ehf
Profiel
Kári Stefánsson is the founder of deCODE genetics, Inc. (founded in 1996) and deCODE Genetics ehf (founded in 1996).
He holds the titles of President & President-Research at deCODE genetics, Inc. in 2010 and Chief Executive Officer at deCODE Genetics ehf.
Dr. Stefánsson is also the founder of DGI Resolution, Inc. Dr. Stefánsson's current job is as a Director at Genomics Medicine Ireland Ltd since 2017.
His former jobs include being the Director-Neuropathology at Beth Israel Hospital from 1993 to 1997, a Director at Neumora Therapeutics, Inc., and a Professor at Harvard University from 1993 to 1997.
Dr. Stefánsson obtained a doctorate degree from the University of Iceland.
Actieve functies van Kári Stefánsson
| Bedrijven | Functie | Begin |
|---|---|---|
deCODE Genetics ehf
 deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | Chief Executive Officer | 01-08-1996 |
Genomics Medicine Ireland Ltd
 Genomics Medicine Ireland Ltd Information Technology ServicesTechnology Services Genomics Medicine Ireland Ltd. operates as a biotechnology company. It develops new treatments and diagnostics across a spectrum of chronic health conditions. The company was founded by Daniel Crowley, Sean Ennis, Paul Thurk, and Maurice N. Treacy in 2015 and is headquartered in Dublin, Ireland. | Director/Board Member | 05-06-2017 |
Eerdere bekende functies van Kári Stefánsson
| Bedrijven | Functie | Einde |
|---|---|---|
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Founder | 13-07-2010 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-04-1997 |
Beth Israel Hospital
 Beth Israel Hospital Medical/Nursing ServicesHealth Services Beth Israel Hospital provides healthcare services. The private company is based in Boston, MA. | Corporate Officer/Principal | 01-01-1997 |
| NEUMORA THERAPEUTICS, INC. | Director/Board Member | - |
DGI Resolution, Inc.
 DGI Resolution, Inc. Miscellaneous Commercial ServicesCommercial Services DGI Resolution, Inc. operates as a biopharmaceutical company. It discovers human genetics to develop drugs for common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher and is headquartered in New York, NY. | Founder | - |
Opleiding van Kári Stefánsson
| University of Iceland | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
Beth Israel Hospital
Beth Israel Hospital Medical/Nursing ServicesHealth Services Beth Israel Hospital provides healthcare services. The private company is based in Boston, MA. | Health Services |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | Commercial Services |
DGI Resolution, Inc.
DGI Resolution, Inc. Miscellaneous Commercial ServicesCommercial Services DGI Resolution, Inc. operates as a biopharmaceutical company. It discovers human genetics to develop drugs for common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher and is headquartered in New York, NY. | Commercial Services |
Genomics Medicine Ireland Ltd
Genomics Medicine Ireland Ltd Information Technology ServicesTechnology Services Genomics Medicine Ireland Ltd. operates as a biotechnology company. It develops new treatments and diagnostics across a spectrum of chronic health conditions. The company was founded by Daniel Crowley, Sean Ennis, Paul Thurk, and Maurice N. Treacy in 2015 and is headquartered in Dublin, Ireland. | Technology Services |
